🏭Proposed Registration Extension Under Chemical Diversion Act
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More🏥DEA Registration Renewal Notice and Compliance Overview
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More📦DEA Proposed Information Collection for Mail Order Transactions
The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Learn More💊DEA Notice on Continuus Pharmaceuticals' Bulk Manufacturing Application
Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🚫DEA Revokes Registration for Physician Following License Suspension
The Drug Enforcement Administration has issued an Order to Show Cause for the revocation of Kenneth Pherson, D.O.'s registration, citing the suspension of his state medical license in Florida. This decision emphasizes the necessity for practitioners to maintain state authority to prescribe controlled substances, as federal compliance hinges on state licensure. The document details the procedural actions taken by the DEA and the implications of default by the registrant.
Learn More⚖️DEA Temporarily Schedules New Synthetic Opioids - Compliance Needed
The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.
Learn More💊DEA Notice on Experic LLC's Importer Application for Controlled Substances
Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Benuvia Operations LLC Applies for Controlled Substances Import Registration
Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice
Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊DEA Notice
Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More